Evidence map›Paper›PMID 41530528›Full record

ArticleCommunications medicine2026

Automating clinical phenotyping using natural language processing.

Linea Schmidt, Susanne Ibing, Florian Borchert, Julian Hugo, Allison A Marshall, Jellyana Peraza, Judy H Cho, Erwin P Böttinger, Bernhard Y Renard, Ryan C Ungaro

Abstract read
In one paragraph

Article in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Linea Schmidt *Hasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany.ORCID http://orcid.org/0009-0006-3014-4058
Susanne Ibing *Hasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany. susanne.ibing@hpi.de.ORCID http://orcid.org/0000-0003-0445-7588
Florian BorchertHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany.
Julian HugoHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany.
Allison A MarshallDepartment of Medicine, Mount Sinai Health System, New York, NY, USA.
Jellyana PerazaThe Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Judy H ChoDepartment of Pathology, Molecular, and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID http://orcid.org/0000-0002-7959-0466
Erwin P BöttingerHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany.
Bernhard Y RenardHasso Plattner Institute, Digital Engineering Faculty, University of Potsdam, Potsdam, Germany.ORCID http://orcid.org/0000-0003-4589-9809
Ryan C UngaroThe Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. ryan.ungaro@mssm.edu.

Funding

Conduits: Mount Sinai Health System Translational Science HubUL1TR004419 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Rosalind J Wright · 2022 to 2026
$46.4M
Yale University Inflammatory Bowel Disease Genetics Research CenterU01DK062422 · NIDDK · YALE UNIVERSITY · PI Ling-shiang Chuang · 2002 to 2026
$10.8M
Intestinal single cell analyses and population differences in innate immunity in Crohn's disease drive treatment response and clinical heterogeneity: towards Precision IBDR01DK123758 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHO, JUDY H. · 2020 to 2023
$2.9M
Big Omics Data Engine 2 SupercomputerS10OD026880 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2019 to 2019
$2.0M
Blood Protein Markers of Biologic Treatment Response in Crohn's DiseaseR03DK132440 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI UNGARO, RYAN · 2023 to 2024
$248k
NCATS NIH HHS UL1 TR004419NIDDK NIH HHS R01 DK123758NIDDK NIH HHS R03 DK132440NIDDK NIH HHS U01 DK062422NIH HHS S10 OD026880
6 · The paper itself

Abstract

backgroundReal-world studies based on electronic health records often require manual chart review to derive patients' clinical phenotypes, a labor-intensive task with limited scalability. Here, we developed and compared computable phenotyping based on rules using the spaCy framework and a Large Language Model (LLM), GPT-4, for sub-phenotyping of patients with Crohn's disease, considering age at diagnosis and disease behavior.

methodsFor our rule-based approach, we leveraged the spaCy framework and for the LLM-based approach, we used the GPT-4 model. The underlying data included 49,572 clinical notes and 2204 radiology reports from 584 Crohn's disease patients. A test set of 280 clinical texts was labeled at sentence-level, in addition to patient-level ground truth data. The algorithms were evaluated based on their recall, precision, specificity values, and F1 scores.

resultsOverall, we observe similar or better performance using GPT-4 compared to the rules. On a note-level, the F1 score is at least 0.90 for disease behavior and 0.82 for age at diagnosis, and on patient level at least 0.66 for disease behavior and 0.71 for age at diagnosis.

conclusionsTo our knowledge, this is the first study to explore computable phenotyping algorithms based on clinical narrative text for these complex tasks, where prior inter-annotator agreements ranged from 0.54 to 0.98. There is no statistical evidence for a difference to the performance of human experts on this task. Our findings underline the potential of LLMs for computable phenotyping and may support large-scale cohort analyses from electronic health records and streamline chart review processes in the future.

Identifiers

PMID41530528
PMCPMC12873203

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.